FRM
Fox Run Management’s Aldeyra Therapeutics ALDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-22,912
| Closed | -$132K | – | 831 |
|
|
2025
Q1 | $132K | Buy |
+22,912
| New | +$132K | 0.02% | 845 |
|
|
2024
Q4 | – | Sell |
-19,002
| Closed | -$102K | – | 841 |
|
|
2024
Q3 | $102K | Buy |
+19,002
| New | +$102K | 0.02% | 739 |
|
|
2023
Q4 | – | Sell |
-33,519
| Closed | -$224K | – | 704 |
|
|
2023
Q3 | $224K | Buy |
+33,519
| New | +$224K | 0.07% | 532 |
|
|
2023
Q2 | – | Sell |
-23,317
| Closed | -$232K | – | 661 |
|
|
2023
Q1 | $232K | Buy |
23,317
+10,635
| +84% | +$106K | 0.08% | 475 |
|
|
2022
Q4 | $88.3K | Buy |
+12,682
| New | +$88.3K | 0.04% | 570 |
|